Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5671)
Hepion Pharmaceuticals, Inc. (HEPA)
Purcell Michael J. — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. II — Director
Shares
500,000
Price
$0.05
Total Value
$25.00K
Shares Held After
500,000
% of Holdings
100.0%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
BIOGEN INC. (BIIB)
Minor Lloyd — Director
Shares
593
Price
$203.34
Total Value
$120.58K
Shares Held After
3,282
% of Holdings
15.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
4,375
Price
$26.12
Total Value
$114.26K
Shares Held After
717,203
% of Holdings
0.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
955
Price
$26.12
Total Value
$24.94K
Shares Held After
119,289
% of Holdings
0.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
1,230
Price
$26.12
Total Value
$32.12K
Shares Held After
126,171
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
100
Price
$97.10
Total Value
$9.71K
Shares Held After
97,994
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,300
Price
$96.30
Total Value
$221.49K
Shares Held After
98,094
% of Holdings
2.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,100
Price
$95.21
Total Value
$485.57K
Shares Held After
100,394
% of Holdings
4.8%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
16
Price
$97.46
Total Value
$1.56K
Shares Held After
567,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
1,392
Price
$96.82
Total Value
$134.77K
Shares Held After
567,556
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,635
Price
$95.93
Total Value
$540.57K
Shares Held After
568,948
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
7,157
Price
$95.10
Total Value
$680.63K
Shares Held After
574,583
% of Holdings
1.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
800
Price
$93.97
Total Value
$75.18K
Shares Held After
581,740
% of Holdings
0.1%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
334
Price
$267.99
Total Value
$89.51K
Shares Held After
170,073
% of Holdings
0.2%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
317
Price
$267.99
Total Value
$84.95K
Shares Held After
52,115
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
109
Price
$267.99
Total Value
$29.21K
Shares Held After
245,614
% of Holdings
0.0%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
731
Price
$267.99
Total Value
$195.90K
Shares Held After
2,275,394
% of Holdings
0.0%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
128
Price
$268.70
Total Value
$34.39K
Shares Held After
129,019
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,233
Price
$267.79
Total Value
$330.18K
Shares Held After
129,147
% of Holdings
0.9%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
192
Price
$265.27
Total Value
$50.93K
Shares Held After
130,380
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
947
Price
$263.94
Total Value
$249.95K
Shares Held After
130,572
% of Holdings
0.7%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
200
Price
$261.49
Total Value
$52.30K
Shares Held After
131,519
% of Holdings
0.2%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
300
Price
$259.98
Total Value
$77.99K
Shares Held After
131,719
% of Holdings
0.2%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
410
Price
$267.99
Total Value
$109.88K
Shares Held After
132,019
% of Holdings
0.3%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
612
Price
$268.22
Total Value
$164.15K
Shares Held After
99,897
% of Holdings
0.6%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
296
Price
$267.08
Total Value
$79.06K
Shares Held After
100,509
% of Holdings
0.3%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
80
Price
$265.27
Total Value
$21.22K
Shares Held After
100,805
% of Holdings
0.1%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
676
Price
$263.86
Total Value
$178.37K
Shares Held After
100,885
% of Holdings
0.7%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
70
Price
$261.02
Total Value
$18.27K
Shares Held After
101,561
% of Holdings
0.1%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
160
Price
$259.98
Total Value
$41.60K
Shares Held After
101,631
% of Holdings
0.2%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
295
Price
$267.99
Total Value
$79.06K
Shares Held After
183,774
% of Holdings
0.2%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
1,182
Price
$267.99
Total Value
$316.76K
Shares Held After
101,791
% of Holdings
1.1%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
6,250
Price
$137.37
Total Value
$858.56K
Shares Held After
162,500
% of Holdings
3.7%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
6,250
Price
$137.37
Total Value
$858.56K
Shares Held After
168,750
% of Holdings
3.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
82
Price
$139.20
Total Value
$11.41K
Shares Held After
0
% of Holdings
100.0%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
760
Price
$138.09
Total Value
$104.95K
Shares Held After
82
% of Holdings
90.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
3,125
Price
$137.25
Total Value
$428.89K
Shares Held After
842
% of Holdings
78.8%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,983
Price
$136.42
Total Value
$270.53K
Shares Held After
3,967
% of Holdings
33.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
43
Price
$135.41
Total Value
$5.82K
Shares Held After
5,950
% of Holdings
0.7%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
173
Price
$133.81
Total Value
$23.15K
Shares Held After
5,993
% of Holdings
2.8%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
84
Price
$133.01
Total Value
$11.17K
Shares Held After
6,166
% of Holdings
1.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
82
Price
$139.21
Total Value
$11.42K
Shares Held After
6,250
% of Holdings
1.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
762
Price
$138.09
Total Value
$105.22K
Shares Held After
6,332
% of Holdings
10.7%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
3,124
Price
$137.25
Total Value
$428.75K
Shares Held After
7,094
% of Holdings
30.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,981
Price
$136.42
Total Value
$270.26K
Shares Held After
10,218
% of Holdings
16.2%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
44
Price
$135.41
Total Value
$5.96K
Shares Held After
12,199
% of Holdings
0.4%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
173
Price
$133.81
Total Value
$23.15K
Shares Held After
12,243
% of Holdings
1.4%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
84
Price
$133.00
Total Value
$11.17K
Shares Held After
12,416
% of Holdings
0.7%
Showing 351–400 of 5671 transactions (page 8 of 114)